Cargando…

Randomised controlled trial comparing rituximab to mycophenolate mofetil in children and young adults with steroid-dependent idiopathic nephrotic syndrome: study protocol

INTRODUCTION: Glucocorticoids induce remission in 90% of children with idiopathic nephrotic syndrome (INS). Some become steroid-dependent (SD) and require the addition of steroid sparing drugs such as calcineurin-inhibitors (CNI) or cyclophosphamide, to maintain remission. Considering the toxicity o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lugani, Francesca, Angeletti, Andrea, Ravani, Pietro, Vivarelli, Marina, Colucci, Manuela, Caridi, Gianluca, Verrina, Enrico, Emma, Francesco, Ghiggeri, Gian Marco
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2021
Materias:	Renal Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8634023/ https://www.ncbi.nlm.nih.gov/pubmed/34845071 http://dx.doi.org/10.1136/bmjopen-2021-052450

Ejemplares similares

Circulating Anti-Rituximab Antibodies Do Not Affect Response to Rituximab in Steroid-Dependent Nephrotic Syndrome
por: Angeletti, Andrea, et al.
Publicado: (2022)

Randomised controlled trial comparing ofatumumab to rituximab in children with steroid-dependent and calcineurin inhibitor-dependent idiopathic nephrotic syndrome: study protocol
por: Ravani, Pietro, et al.
Publicado: (2017)

Vaccines and nephrotic syndrome: efficacy and safety
por: Angeletti, Andrea, et al.
Publicado: (2022)

Biologics in steroid resistant nephrotic syndrome in childhood: review and new hypothesis-driven treatment
por: Angeletti, Andrea, et al.
Publicado: (2023)

Mycophenolate mofetil in children with steroid-dependent and/or frequently relapsing nephrotic syndrome
por: Al-Akash, Samhar, et al.
Publicado: (2005)

Effect of mycophenolate mofetil on progression of interstitial fibrosis and tubular atrophy after kidney transplantation: a retrospective study
por: Mihovilović, Karlo, et al.
Publicado: (2014)

Efficacy and safety of intravenous immunoglobulin with rituximab versus rituximab alone in childhood-onset steroid-dependent and frequently relapsing nephrotic syndrome: protocol for a multicentre randomised controlled trial
por: Hogan, Julien, et al.
Publicado: (2020)

An update on COVID-19 in paediatric and young adults with nephrotic syndrome, receiving chronic immunosuppression during the Omicron pandemic
por: Angeletti, Andrea, et al.
Publicado: (2022)

Mycophenolate mofetil therapy for steroid-resistant IgA nephropathy with the nephrotic syndrome in children
por: Kang, Zhijuan, et al.
Publicado: (2015)

Protocol for an open-label, single-arm, multicentre clinical study to evaluate the efficacy and safety of rituximab in the first episode of paediatric idiopathic nephrotic syndrome
por: Liu, Jialu, et al.
Publicado: (2022)

Efficacy of Mycophenolate Mofetil as a Remission Maintaining Agent in Idiopathic Childhood Nephrotic Syndrome
por: Nandi, M., et al.
Publicado: (2019)

Randomized clinical trial to compare efficacy and safety of repeated courses of rituximab to single-course rituximab followed by maintenance mycophenolate-mofetil in children with steroid dependent nephrotic syndrome
por: Basu, Biswanath, et al.
Publicado: (2020)

Refractory pemphigus vulgaris treated with rituximab and mycophenolate mofetil
por: Biot, Stephanie Del Rio Navarrete, et al.
Publicado: (2014)

Steroid Refractory Autoimmune Haemolytic Anaemia Secondary to Sarcoidosis Successfully Treated with Rituximab and Mycophenolate Mofetil
por: Green, Sarah, et al.
Publicado: (2016)

Mycophenolate mofetil versus cyclosporine for remission maintenance in nephrotic syndrome
por: Dorresteijn, Eiske M., et al.
Publicado: (2008)

Renal involvement and Strømme syndrome
por: Caridi, Gianluca, et al.
Publicado: (2020)

Mycophenolate Mofetil in the Treatment of Steroid-Dependent or Frequently Relapsing Nephrotic Syndrome in Children: A Meta-Analysis
por: Xiang, Xin, et al.
Publicado: (2021)

Infiltrative lymphocytic hypophysitis successfully treated with rituximab and mycophenolate mofetil
por: Lin, Mike, et al.
Publicado: (2020)

The safety and efficacy of mycophenolate mofetil in children and adolescents with steroid-dependent nephrotic syndrome: a single-centre study
por: Karunamoorthy, Saravanakumar, et al.
Publicado: (2019)

Idiopathic membranoproliferative glomerulonephritis treated with mycophenolate mofetil
por: Koratala, Abhilash, et al.
Publicado: (2018)

Rituximab Treatment for Nephrotic Syndrome in Children
por: Iijima, Kazumoto, et al.
Publicado: (2014)

A Pilot Study of IL2 in Drug-Resistant Idiopathic Nephrotic Syndrome
por: Bonanni, Alice, et al.
Publicado: (2015)

Refractory Minimal Change Disease and Focal Segmental Glomerular Sclerosis Treated With Anakinra
por: Angeletti, Andrea, et al.
Publicado: (2021)

Hydroxychloroquine/mycophenolate mofetil/rituximab: Human coronavirus infection: case report
Publicado: (2022)

Familial forms of nephrotic syndrome
por: Caridi, Gianluca, et al.
Publicado: (2010)

Effect and Safety of Mycophenolate Mofetil in Idiopathic Pulmonary Fibrosis
por: Tzouvelekis, Argyris, et al.
Publicado: (2011)

Effectiveness and safety of mycophenolate mofetil in idiopathic pulmonary fibrosis
por: Nambiar, Anoop M., et al.
Publicado: (2017)

Initial treatment of steroid-sensitive idiopathic nephrotic syndrome in children with mycophenolate mofetil versus prednisone: protocol for a randomised, controlled, multicentre trial (INTENT study)
por: Ehren, Rasmus, et al.
Publicado: (2018)

Low dose of mycophenolate mofetil is enough in desensitized kidney transplantation using rituximab
por: Baek, Chung Hee, et al.
Publicado: (2015)

Efficacy of mycophenolate treatment in adults with steroid-dependent/frequently relapsing idiopathic nephrotic syndrome
por: Sandoval, Diego, et al.
Publicado: (2017)

Mycophenolate mofetil/sirolimus/steroids: COVID-19 pneumonia: case report
Publicado: (2021)

Ciclosporin/mycophenolate-mofetil/steroids: COVID-19 pneumonia: case report
Publicado: (2021)

Mechanisms Limiting Renal Tissue Protection and Repair in Glomerulonephritis
por: Angeletti, Andrea, et al.
Publicado: (2023)

CyTOF-Enabled Analysis Identifies Class-Switched B Cells as the Main Lymphocyte Subset Associated With Disease Relapse in Children With Idiopathic Nephrotic Syndrome
por: Fribourg, Miguel, et al.
Publicado: (2021)

Immune globulin/mycophenolate mofetil/rituximab: Breakthrough COVID-19: 2 case reports
Publicado: (2022)

Mycophenolate-mofetil/prednisolone/rituximab: Treatment-related osteopenia and candidiasis: 7 case reports
Publicado: (2022)

A Case of Anti-Synthetase Syndrome Successfully Treated with Mycophenolate Mofetil and Rituximab but No Corticosteroids
por: Sieradzka, Agnieszka Ewa, et al.
Publicado: (2022)

Study protocol: mycophenolate mofetil as maintenance therapy after rituximab treatment for childhood-onset, complicated, frequently-relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicenter double-blind, randomized, placebo-controlled trial (JSKDC07)
por: Horinouchi, Tomoko, et al.
Publicado: (2018)

Mycophenolate mofetil as a possible therapeutic option for idiopathic membranoproliferative glomerulonephritis
por: Kazory, Amir, et al.
Publicado: (2008)

Children with Steroid Dependent Nephrotic Syndrome: Rituximab or Tacrolimus? It’s All in the Timing
por: Qader, Md Abdul, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_kbo10ubk2fj46iqb2ljjujtfbo